-
LRMR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Larimar Therapeutics (LRMR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 36.41 mm | 36.41 mm | 36.41 mm | 36.41 mm | 36.41 mm | 36.41 mm |
Cash burn (monthly) | (no burn) | 304.50 k | 6.09 mm | 6.15 mm | 8.18 mm | 4.86 mm |
Cash used (since last report) | n/a | 1.54 mm | 30.82 mm | 31.12 mm | 41.42 mm | 24.59 mm |
Cash remaining | n/a | 34.86 mm | 5.58 mm | 5.29 mm | -5.02 mm | 11.81 mm |
Runway (months of cash) | n/a | 114.5 | 0.9 | 0.9 | -0.6 | 2.4 |
13F holders | Current |
---|---|
Total holders | 121 |
Opened positions | 23 |
Closed positions | 28 |
Increased positions | 44 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 244.61 bn |
Total shares | 85.62 mm |
Total puts | 61.20 k |
Total calls | 499.70 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 21.27 mm | $184.97 mm |
Deerfield Management | 21.23 mm | $82.17 bn |
JHG Janus Henderson | 6.44 mm | $24.94 bn |
Ra Capital Management | 6.05 mm | $23.40 bn |
Blue Owl Capital | 4.65 mm | $18.01 bn |
GS The Goldman Sachs Group, Inc. | 4.15 mm | $16.07 bn |
BlackRock | 3.27 mm | $12.64 bn |
Vanguard | 2.19 mm | $8.49 bn |
Adage Capital Partners GP, L.L.C. | 2.10 mm | $8.13 bn |
Driehaus Capital Management | 1.27 mm | $4.91 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 25 | Russell Clayton | Common Stock | Grant | Acquire A | No | No | 0 | 23,306 | 0.00 | 45,806 |
22 Jan 25 | Russell Clayton | Stock Option Common Stock | Grant | Acquire A | No | No | 3.46 | 139,838 | 483.84 k | 139,838 |
22 Jan 25 | Gopi Shankar | Common Stock | Grant | Acquire A | No | No | 0 | 23,306 | 0.00 | 50,806 |
22 Jan 25 | Gopi Shankar | Stock Option Common Stock | Grant | Acquire A | No | No | 3.46 | 139,838 | 483.84 k | 139,838 |
22 Jan 25 | Ben-maimon Carole | Common Stock | Grant | Acquire A | No | No | 0 | 91,000 | 0.00 | 387,208 |
22 Jan 25 | Ben-maimon Carole | Stock Option Common Stock | Grant | Acquire A | No | No | 3.46 | 546,000 | 1.89 mm | 546,000 |
22 Jan 25 | Celano Michael | Common Stock | Grant | Acquire A | No | No | 0 | 34,185 | 0.00 | 178,181 |
22 Jan 25 | Celano Michael | Stock Option Common Stock | Grant | Acquire A | No | No | 3.46 | 205,111 | 709.68 k | 205,111 |
29 May 24 | Truitt Joseph | Stock Option Common Stock | Grant | Acquire A | No | No | 7.07 | 19,000 | 134.33 k | 19,000 |